Here are two stocks I'm planning on adding to my RRSP next month, and why I continue to pound the table on these two ...

Checkpoint Therapeutics' cosibelimab shows strong efficacy in treating cSCC. Learn why CKPT stock could see significant gains ...

I argue that Wesfarmers offers investors both growth and income potential. The post Here's why I think Wesfarmers shares are ...

Your retirement portfolio shouldn't be more than 60% invested in stocks, even if you plan to be working for another 30 or 40 years.

When Rachel got the calendar back in September, it cost a cool £175 - while that's still a pretty good deal considering it's ...

Before you jump into buying stock, first take the time to learn what type of broker-dealer relationship may be right for you.

The Indian stock market closed in the red for the sixth day in a row on Thursday. Social media users took the opportunity to ...

Bank of America reviewed data from over 4 million retirement plan participants in its employee benefits programs, noting that ...

Loring Tu, a mathematics professor at Tufts University for 38 years, has amassed a multi-million dollar fortune by investing ...

Traders see another rate in December as likely after consumer and wholesale inflation this week were in line with ...

I’m 72 and would not consider myself investment-savvy, but I’m beginning to wonder whether our fund is performing ...

After a long bull run, most stocks offer uninspiring dividend yields. Brookfield Infrastructure, Realty Income, and Royalty Pharma are dividend-paying stocks that offer yields above 3% at recent ...